IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults
Open Access
- 17 May 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 40 (4), 475-481
- https://doi.org/10.1093/ageing/afr047
Abstract
Background: neopterin is a monocyte/macrophage-derived immune activation marker and its levels increase with age. Frailty is an important clinical syndrome of old age. Previous studies have shown significant association between elevated interleukin-6 (IL-6) levels and frailty. The objective of this study was to evaluate IL-6-independent association of serum neopterin levels with prevalent frailty. Methods: this is a cross-sectional study in community-dwelling older adults recruited from residential and retirement communities in Baltimore, MD, USA. Frailty was determined using validated screening criteria. Serum neopterin and IL-6 levels were measured using standard enzyme-linked immunosorbent assay. Pearson correlation and multivariate linear regression analysis was performed to assess the relationship between log(neopterin) and log(IL-6). Odds ratios (ORs) for frailty were calculated using log(neopterin) and log(IL-6) as continuous measures and across tertiles of neopterin and IL-6 levels, adjusting for age, race, sex, education and body mass index. Results: one hundred and thirty-three individuals with a mean age of 84 years (range 72–97) completed the study. Neopterin levels were significantly higher in frail older adults than those in non-frail controls [median: 8.94 versus 8.35 nM, respectively, P < 0.001 t-test on log(neopterin)]. Log(neopterin) was significantly associated with prevalent frailty, adjusting for log(IL-6). Participants in the top tertile of neopterin had OR of 3.80 [95% confidence interval (CI) = 1.36–10.6, P < 0.01] for frailty. As expected, participants in the top tertile of IL-6 had OR of 3.29 (95% CI = 1.21–7.86, P < 0.05) for frailty. Log(neopterin) correlated with log(IL-6) (correlation coefficient = 0.19, P < 0.05). Moreover, OR for participants in the top neopterin tertile remained significant after adjusting for IL-6 (OR = 3.97, 95% CI = 1.15–13.72, P < 0.05). Conclusion: elevated neopterin levels had IL-6-independent association with prevalent frailty, suggesting potential monocyte/macrophage-mediated immune activation in the frail elderly.Keywords
This publication has 28 references indexed in Scilit:
- Serum Levels of the Immune Activation Marker Neopterin Change With Age and Gender and Are Modified by Race, BMI, and Percentage of Body FatThe Journals of Gerontology: Series A, 2010
- Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: Results from the Women’s Health and Aging Studies IExperimental Gerontology, 2009
- Nonlinear Multisystem Physiological Dysregulation Associated With Frailty in Older Women: Implications for Etiology and TreatmentThe Journals of Gerontology: Series A, 2009
- Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailtyCytokine, 2009
- Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14+ monocytes in frail older adultsMechanisms of Ageing and Development, 2009
- Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infectionTransfusion, 2006
- Chronic Cytomegalovirus Infection and Inflammation Are Associated with Prevalent Frailty in Community‐Dwelling Older WomenJournal of the American Geriatrics Society, 2005
- Serum Neopterin, an Immune Activation Marker, Independently Predicts Disease Progression in Advanced HIV-1 InfectionClinical Infectious Diseases, 2005
- Association of increased neopterin production with decreased humoral immunity in the elderlyExperimental Gerontology, 2003
- Serum soluble markers of immune activation and disease activity in systemic lupus erythematosusLupus, 1995